Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
- 30 November 2011
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 58 (5), 717-728
- https://doi.org/10.1053/j.ajkd.2011.05.020
Abstract
No abstract availableKeywords
Funding Information
- Amgen
This publication has 32 references indexed in Scilit:
- Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort StudyAmerican Journal of Kidney Diseases, 2010
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkersStatistics in Medicine, 2010
- Value ofN-terminal brain natriuretic peptide as a prognostic marker in patients with CKD: results from the CREATE studyCurrent Medical Research and Opinion, 2010
- Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred CohortAmerican Journal of Kidney Diseases, 2008
- Response to Letter Regarding Article by Khan et al, “Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis”Circulation, 2006
- Role of Diminished Renal Function in Cardiovascular MortalityJournal of the American College of Cardiology, 2005
- Cardiac Troponins and Renal FailureCirculation, 2005
- Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal DiseaseCirculation, 2005
- Cardiac troponins in renal insufficiencyJournal of the American College of Cardiology, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999